Award ID: 75A50126F61020
| Mod # | Date | Amount | Action Type | Description |
|---|---|---|---|---|
| — | Mar 30, 2026 | $493K | Two-way immunogenicity testing on existing clinical trial sera to immunogeni... |
This contract was awarded to GLAXOSMITHKLINE, LLC (based in North Carolina) by Department of Health and Human Services, specifically the Office of Assistant Secretary for Preparedness and Response sub-agency. The award represents one of millions of federal procurement actions tracked through USASpending.gov, the official source of federal spending data.
The obligated amount is $493,470. Federal contract obligations represent funds committed by the government for goods or services. Actual outlays may differ if contract modifications, terminations, or scope changes occur during the period of performance.
This contract is classified under NAICS code 541714 — Research and Development in Biotechnology (except Nanobiotechnology). The North American Industry Classification System (NAICS) is used by federal agencies to categorize establishments by their primary business activity. Browse all federal contracts under NAICS 541714 to compare similar awards by amount, agency, and recipient.
The place of performance for this contract is North Carolina, specifically in or around DURHAM. Federal contracts are distributed across all 50 states, with concentrations in defense corridors and metropolitan areas hosting major federal facilities.